Market Tracker

02/16 5:15pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

64.00
Delayed Data
As of Feb 16
 +0.86 / +1.36%
Today’s Change
26.96
Today|||52-Week Range
68.90
+15.03%
Year-to-Date
With an Eye on Biotech, Here's Today's Trading Thesis
Feb 15 / TheStreet.com - Paid Partner Content
Focused on Two Sectors
Feb 13 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close63.14
Today’s open62.72
Day’s range62.01 - 64.49
Volume1,836,381
Average volume (3 months)1,724,773
Market cap$4.1B
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+86.01%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book10.41

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-2.33-2.80%
LOXOLoxo Oncology Inc-0.17-0.16%
RAREUltragenyx Pharmaceu...-0.40-0.84%
IRWDIronwood Pharmaceuti...-0.14-0.90%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts